Center-Authored Papers

Filters: Author is Boudreau, Denise M  [Clear All Filters]
2008
Chubak J, Buist DSM, Boudreau DM, Rossing MA, Lumley T, Weiss NS.  2008.  Breast cancer recurrence risk in relation to antidepressant use after diagnosis.. Breast cancer research and treatment. 112(1):123-32. Abstract
Boudreau DM, Koehler E, Rulyak SJ, Haneuse S, Harrison R, Mandelson MT.  2008.  Cardiovascular medication use and risk for colorectal cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(11):3076-80. Abstract
2009
Chubak J, Boudreau DM, Rulyak SJ, Mandelson MT.  2009.  Colorectal cancer risk in relation to use of acid suppressive medications.. Pharmacoepidemiology and drug safety. 18(7):540-4. Abstract
2011
Chubak J, Boudreau DM, Rulyak SJ, Mandelson MT.  2011.  Colorectal cancer risk in relation to antidepressant medication use.. International journal of cancer. Journal international du cancer. 128(1):227-32. Abstract
2013
Spangler L, Yu O, Loggers E, Boudreau DM.  2013.  Bone mineral density screening among women with a history of breast cancer treated with aromatase inhibitors.. Journal of women's health (2002). 22(2):132-40. Abstract
Calip GS, Boudreau DM, Loggers ET.  2013.  Changes in adherence to statins and subsequent lipid profiles during and following breast cancer treatment.. Breast cancer research and treatment. 138(1):225-33. Abstract
Chubak J, Boudreau DM, Wirtz HS, McKnight B, Weiss NS.  2013.  Threats to validity of nonrandomized studies of postdiagnosis exposures on cancer recurrence and survival.. Journal of the National Cancer Institute. 105(19):1456-62. Abstract
Wirtz HS, Buist DSM, Gralow JR, Barlow WE, Gray S, Chubak J, Yu O, Bowles EJA, Fujii M, Boudreau DM.  2013.  Frequent antibiotic use and second breast cancer events.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 22(9):1588-99. Abstract
2014
Wirtz HS, Boudreau DM, Gralow JR, Barlow WE, Gray S, Bowles EJA, Buist DSM.  2014.  Factors associated with long-term adherence to annual surveillance mammography among breast cancer survivors.. Breast cancer research and treatment. 143(3):541-50. Abstract
Calip GS, Hubbard RA, Stergachis A, Malone KE, Gralow JR, Boudreau DM.  2014.  Adherence to oral diabetes medications and glycemic control during and following breast cancer treatment.. Pharmacoepidemiology and drug safety. Abstract
Calip GS, Malone KE, Gralow JR, Stergachis A, Hubbard RA, Boudreau DM.  2014.  Metabolic syndrome and outcomes following early-stage breast cancer.. Breast cancer research and treatment. 148(2):363-77. Abstract
2015
Calip GS, Yu O, Hoskins KF, Boudreau DM.  2015.  Associations between diabetes medication use and risk of second breast cancer events and mortality.. Cancer causes & control : CCC. 26(8):1065-77. Abstract
Hansen RN, Boudreau DM, Ebel BE, Grossman DC, Sullivan SD.  2015.  Sedative Hypnotic Medication Use and the Risk of Motor Vehicle Crash.. American journal of public health. :e1-e6. Abstract
2016
Drieling RL, LaCroix AZ, Beresford SAA, Boudreau DM, Kooperberg C, Chlebowski RT, Gass M, Crandall CJ, Womack CR, Heckbert SR.  2016.  Long-term oral bisphosphonate use in relation to fracture risk in postmenopausal women with breast cancer: findings from the Women's Health Initiative.. Menopause (New York, N.Y.). 23(11):1168-1175. Abstract
Hart R, Veenstra DL, Boudreau DM, Roth JA.  2016.  The Impact of Body Mass Index and Genetics on Warfarin Major Bleeding Outcomes in a Community Setting.. The American journal of medicine. Abstract
2017
Wirtz HS, Calip GS, Buist DSM, Gralow JR, Barlow WE, Gray S, Boudreau DM.  2017.  Evidence for Detection Bias by Medication Use in a Cohort Study of Breast Cancer Survivors.. American journal of epidemiology. 185(8):661-672. Abstract
Chen L, Chubak J, Boudreau DM, Barlow WE, Weiss NS, Li CI.  2017.  Use of antihypertensive medications and risk of adverse breast cancer outcomes in a SEER-Medicare population.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Veenstra DL, Guzauskas GF, Villa KF, Boudreau DM.  2017.  The budget impact and cost-effectiveness of defibrotide for treatment of veno-occlusive disease with multi-organ dysfunction in patients post-hematopoietic stem cell transplant.. Journal of medical economics. 20(5):453-463. Abstract
Drieling RL, LaCroix AZ, Beresford SAA, Boudreau DM, Kooperberg C, Chlebowski RT, Ko MG, Heckbert SR.  2017.  Long-Term Oral Bisphosphonate Therapy and Fractures in Older Women: The Women's Health Initiative.. Journal of the American Geriatrics Society. Abstract